Calithera Biosciences
VerifiedDeveloping novel small molecule therapeutics for the treatment of cancer.
Launch date
Employees
Market cap
$48.7k
Net debt
$1.4m
Enterprise valuation
($1m) (Public information from Jun 2024)
Share price
$0.01 CALA
South San Francisco California (HQ)
| USD | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | (15 %) | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | - | - | (140 %) | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (104 %) | (245 %) | - | - | (1180 %) | - |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | - | - | 190 % | - | - | 548 % | - |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
* | N/A | $10.0m | Post IPO Equity |
| Total Funding | 000k | ||
Related Content
Recent News about Calithera Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.